Clinical Chemistry
News on clinical chemistry systems and applications.
Revenues for Roche Diagnostics totaled CHF 3.33 billion in Q3, with the base business up 7 percent, excluding COVID-19-related testing.
Abbott Focusing on Base Business Recovery, but COVID-19 Testing Remains Crucial Revenue Source
Premium
The company is working to expand the test menus on its instruments and capitalizing on new placements to gain further market share.
Quidel to Acquire Ortho Clinical Diagnostics for $6B
The firms expect the deal will lead to cost synergies of $90 million by end of year three, and revenue synergies greater than $100 million by 2025.
Abbott Q3 Diagnostics Revenues Rise 48 Percent on Core Lab, Rapid Diagnostics Sales Growth
The firm said its global COVID-19 testing-related sales were $1.9 billion in the third quarter, while its Rapid Diagnostics revenues rose 145 percent year over year.
Ochsner Health Integrating ActX Genomic Decision Support to Pilot Cancer PGx Project
The ActX platform will allow physicians to check drug-gene interactions in real time in the EHR workflow against the therapies cancer patients are prescribed.